Literature DB >> 28501073

Prophylactic Hemodialysis for Protection Against Gadolinium-Induced Nephrogenic Systemic Fibrosis: A Doll's House.

Jerry Yee1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28501073     DOI： 10.1053/j.ackd.2017.03.007

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN： 1548-5595            Impact factor:   3.620


× No keyword cloud information.
  4 in total

Review 1.  Gadolinium-based contrast agents: why nephrologists need to be concerned.

Authors:  Katarina Leyba; Brent Wagner
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-03       Impact factor: 2.894

Review 2.  Gadolinium-Based Contrast Agents: Updates and Answers to Typical Questions Regarding Gadolinium Use.

Authors:  Benjamin Y C Cheong; James M Wilson; Ourania A Preventza; Raja Muthupillai
Journal:  Tex Heart Inst J       Date:  2022-05-01

Review 3.  Use of Intravenous Gadolinium-Based Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation.

Authors:  Jeffrey C Weinreb; Roger A Rodby; Jerry Yee; Carolyn L Wang; Derek Fine; Robert J McDonald; Mark A Perazella; Jonathan R Dillman; Matthew S Davenport
Journal:  Kidney Med       Date:  2020-11-10

Review 4.  Nephrogenic Systemic Fibrosis in Patients with Chronic Kidney Disease after the Use of Gadolinium-Based Contrast Agents: A Review for the Cardiovascular Imager.

Authors:  Sebastian Gallo-Bernal; Nasly Patino-Jaramillo; Camilo A Calixto; Sergio A Higuera; Julian F Forero; Juliano Lara Fernandes; Carlos Góngora; Michael S Gee; Brian Ghoshhajra; Hector M Medina
Journal:  Diagnostics (Basel)       Date:  2022-07-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.